EGFR and non-small cell lung carcinoma: Furthermore, we found that even in a tumor type such as NSCLC, which has previously been reported to have a prevalence of only 20% of patients having any CTCs [18], we were able to capture at least one CTC and quantitate EGFR expression in blood samples from 24 out of 34 patients we evaluated.